Presentation ACC 2024 Principal Results From the Double-blind, Placebo-controlled ULTIMATE-DAPT Trial Presenter: Gregg W Stone April 07, 2024 REGISTER for free or LOG IN to view this content Coronary CAD Pharma ACS/AMI Presentation ACC 2024 Up Next Presentation ACC 2024 Gamification, Financial Incentives, or Both to Increase Physical Activity Among Patients at High Risk of Cardiovascular Events: The BE ACTIVE Randomized Controlled Trial Presenter: Alexander Fanaroff April 07, 2024 More slides + Presentation ACC 2024 The Effect of Edetate Disodium-based Chelation on Cardiovascular Events in Patients with a Prior Myocardial Infarction and Diabetes – Results of the TACT2 Randomized Trial Presenter: Gervasio A. Lamas April 07, 2024 Presentation ACC 2024 Self-Expanding Versus Balloon-Expandable TAVR in Patients with Aortic Stenosis and Small Aortic Annuli Presenter: Howard C. Herrmann April 07, 2024 We Recommend
Presentation ACC 2024 Gamification, Financial Incentives, or Both to Increase Physical Activity Among Patients at High Risk of Cardiovascular Events: The BE ACTIVE Randomized Controlled Trial Presenter: Alexander Fanaroff April 07, 2024
Presentation ACC 2024 The Effect of Edetate Disodium-based Chelation on Cardiovascular Events in Patients with a Prior Myocardial Infarction and Diabetes – Results of the TACT2 Randomized Trial Presenter: Gervasio A. Lamas April 07, 2024
Presentation ACC 2024 Self-Expanding Versus Balloon-Expandable TAVR in Patients with Aortic Stenosis and Small Aortic Annuli Presenter: Howard C. Herrmann April 07, 2024